Lee's Pharmaceutical hits 2-month high on unit's listing plan

Lees Pharmaceutical Holdings

21/12/2020 03:02

** Shares of Lee's Pharmaceutical Holdings Ltd  0950.HK 
surge as much as 19.4% to HK$5.18, their highest since Oct. 21,
on course to snap two consecutive sessions of declines
    ** Stock last up 17.5%, set for the best session since July
14 
    ** Pharmaceutical products maker says it has submitted an
application to the Hong Kong bourse for a listing of its
34.1%-owned Zhaoke Ophthalmology Ltd on the main board, raising
proceeds to develop ophthalmic business  urn:newsml:reuters.com:*:nFWN2IY0A3
    ** The Hong Kong Hang Seng Commerce & Industry Index  .HSNC 
gains 0.1%
    ** The Hang Seng China enterprises index  .HSCE  edges down
0.2%, and the benchmark index  .HSI  slips 0.3%
    ** As of last close, the stock had gained 1.8% this year

 (Reuters Messaging: donny.kwok.thomsonreuters.com@reuters.net)